| Lung Adenocarcinoma studied in …STUDIED_INderived200 of 231show all (up to 200) |
|---|
| → studied in | NCT07705035Phase 1 · recruiting DBC-664 in Adult Patients With Solid Tumors · condition mapped ONTOLOGY_EXACT · 231 trials mapped (75 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03391869Phase 3 · active not recruiting Nivolumab and Ipilimumab With or Without Local Consolidation Therapy in Treating Patients With Stage IV Non-Small Cell Lung Cancer · condition mapped ONTOLOGY_EXACT · 231 trials mapped (75 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04105270Phase 2 · recruiting RMT in Combination With Durvalumab + Chemo in Untreated Adenocarcinoma NSCLC. A Randomized Double Blind Phase II Trial · condition mapped ALIAS · 231 trials mapped (75 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07341737Phase 1/Phase 2 · recruiting SL-28 for Advanced Solid Tumours · condition mapped ONTOLOGY_EXACT · 231 trials mapped (75 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05198830Phase 2 · active not recruiting Testing the Addition of an Anti-Cancer Drug, TRC102, to the Usual Chemotherapy Treatment (Pemetrexed, Cisplatin or Carboplatin) During Radiation Therapy for Stage III Non-Squamous Non-Small Cell Lung Cancer · condition mapped ONTOLOGY_EXACT · 231 trials mapped (75 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00334815Phase 2 · active not recruiting Combination Chemotherapy, Radiation Therapy, and Bevacizumab in Treating Patients With Newly Diagnosed Stage III Non-small Cell Lung Cancer That Cannot Be Removed by Surgery · condition mapped ONTOLOGY_EXACT · 231 trials mapped (75 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05517811recruiting Pre- and Post-operative TEG Indices in Patients With or Without Adenocarcinoma Undergoing Surgical Resection · condition mapped ONTOLOGY_EXACT · 231 trials mapped (75 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05797168Phase 1/Phase 2 · recruiting Phase I/IIa Study of AZD5335 as Monotherapy and Combination Therapy in Participants With Solid Tumors · condition mapped ONTOLOGY_EXACT · 231 trials mapped (75 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04557449Phase 2 · active not recruiting Study to Test the Safety and Tolerability of PF-07220060 in Participants With Advance Solid Tumors · condition mapped ALIAS · 231 trials mapped (75 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04929041Phase 2/Phase 3 · active not recruiting Testing the Addition of Radiation Therapy to the Usual Treatment (Immunotherapy With or Without Chemotherapy) for Advanced Stage Non-small Cell Lung Cancer Patients Who Are PD-L1 Negative · condition mapped ONTOLOGY_EXACT · 231 trials mapped (75 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01386385Phase 1/Phase 2 · active not recruiting Veliparib With or Without Radiation Therapy, Carboplatin, and Paclitaxel in Patients With Stage III Non-small Cell Lung Cancer That Cannot Be Removed by Surgery · condition mapped ONTOLOGY_EXACT · 231 trials mapped (75 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06796816NA · active not recruiting Bioimpedance Analysis in Perioperative Assessment in Thoracic Surgery · condition mapped ALIAS · 231 trials mapped (75 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02186847Phase 2 · completed Chemotherapy and Radiation Therapy With or Without Metformin Hydrochloride in Treating Patients With Stage III Non-small Cell Lung Cancer · condition mapped ONTOLOGY_EXACT · 231 trials mapped (75 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05887492Phase 1/Phase 2 · active not recruiting Study of TNG260 and an Anti-PD Antibody in STK11 Mutated Solid Tumors · condition mapped ONTOLOGY_EXACT · 231 trials mapped (75 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07675876Phase 1 · not yet recruiting Inhaled Cromolyn Sodium in Patients With Locally Advanced Lung Cancer · condition mapped ONTOLOGY_EXACT · 231 trials mapped (75 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04566432completed Therapeutic ResistAnce and Clonal Evolution Assessed With Liquid Biopsy in ICIs Treated NSCLC Patients · condition mapped ALIAS · 231 trials mapped (75 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07636252recruiting Ex Vivo Drug Response Profiling and Outcome Prediction in Lung Adenocarcinoma · condition mapped ONTOLOGY_EXACT · 231 trials mapped (75 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03110978Phase 2 · active not recruiting Stereotactic Body Radiation Therapy With or Without Nivolumab in Treating Patients With Stage I-IIA or Recurrent Non-small Cell Lung Cancer · condition mapped CURATED_BROADER · 231 trials mapped (75 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07624487Phase 2 · recruiting Aumolertinib Combined With Phased Chemotherapy for EGFR L858R Lung Adenocarcinoma · condition mapped ALIAS · 231 trials mapped (75 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02834013Phase 2 · active not recruiting Nivolumab and Ipilimumab in Treating Patients With Rare Tumors · condition mapped ONTOLOGY_EXACT · 231 trials mapped (75 active) | — | — | Minimally Invasive Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03199651NA · recruiting Beating Lung Cancer in Ohio Protocol in Improving Survival in Patients With Stage IV Non-Small Cell Lung Cancer · condition mapped ONTOLOGY_EXACT · 231 trials mapped (75 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07647692not yet recruiting Deep Learning Time-Series Prediction of Long-Term Growth Patterns of Pulmonary Ground-Glass Nodules Using Serial CT · condition mapped ALIAS · 231 trials mapped (75 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07633626recruiting Vortioxetine for Cognitive Function in ALK-positive NSCLC Treated With Lorlatinib · condition mapped ONTOLOGY_EXACT · 231 trials mapped (75 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07630246not yet recruiting CLINICAL STUDY TO IDENTIFY BIOMARKERS FOR TUMOR SPREAD THROUGH AIR SPACES STATUS · condition mapped ONTOLOGY_EXACT · 231 trials mapped (75 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05764954Phase 1 · active not recruiting A Study of Tumor-Treating Fields (TTFields) in People With Lung Adenocarcinoma · condition mapped ALIAS · 231 trials mapped (75 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06843629recruiting Clinical Application of PET Imaging Targeting MSLN in Malignant Tumors · condition mapped ONTOLOGY_EXACT · 231 trials mapped (75 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05456256Phase 2 · recruiting A Study of LP-300 With Carboplatin and Pemetrexed in Never Smokers With Advanced Lung Adenocarcinoma · condition mapped ALIAS · 231 trials mapped (75 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05191485recruiting Shared Decision Making in Patients With Lung Cancer · condition mapped ONTOLOGY_EXACT · 231 trials mapped (75 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05528458Phase 2 · recruiting Osimertinib to Suppress the Progression of Remaining GGN for EGFR Mutation-positive Stage IB-IIIA Lung Adenocarcinoma · condition mapped ONTOLOGY_EXACT · 231 trials mapped (75 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06491225Phase 1 · terminated Autologous Tumor-Infiltrating Lymphocyte (GTE-001 Injection ) for Treatment of Patients With Advanced Lung Adenocarcinoma · condition mapped CURATED_BROADER · 231 trials mapped (75 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04937283NA · recruiting Segmentectomy Versus Lobectomy for Lung Adenocarcinoma ≤ 2cm · condition mapped ONTOLOGY_EXACT · 231 trials mapped (75 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06181812recruiting Pathogenic Variants in Genes Associated With Lung Adenocarcinoma · condition mapped ONTOLOGY_EXACT · 231 trials mapped (75 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06495125Phase 2 · recruiting Defactinib, Avutometinib and Nivolumab for the Treatment of Anti-PD1 Refractory LKB1-Mutant Advanced Non-Small Cell Lung Cancer · condition mapped CURATED_BROADER · 231 trials mapped (75 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07481786Phase 3 · recruiting Bevacizumab Plus FSRT Versus Hippocampus-Avoidant WBRT in Lung Adenocarcinoma With Extensive Brain Metastases · condition mapped ONTOLOGY_EXACT · 231 trials mapped (75 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05665504recruiting Using Biomarkers for Diagnosis, Risk Stratification of Post -Treatment Recurrence and Long-Term Surveillance of Lung Cancer · condition mapped ALIAS · 231 trials mapped (75 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04432207Phase 1 · terminated A Study of IMU-201 (PD1-Vaxx), a B-Cell Immunotherapy, in Adults With Non-Small Cell Lung Cancer · condition mapped ALIAS · 231 trials mapped (75 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07479095NA · recruiting Low-glucose/High-fat Intake Dietary Regimen as a Tool for Empowering Diagnostic Accuracy of 2-[18F]FDG PET/CT in Lepidic-predominant Growth Lung Adenocarcinoma · condition mapped ONTOLOGY_EXACT · 231 trials mapped (75 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04119024Phase 1 · recruiting Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors · condition mapped ONTOLOGY_EXACT · 231 trials mapped (75 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07012759recruiting Pleural Effusion Biomarkers in Lung Adenocarcinoma Patients · condition mapped ONTOLOGY_EXACT · 231 trials mapped (75 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07219251NA · recruiting Engagement of Veterans With Lung Cancer · condition mapped ONTOLOGY_EXACT · 231 trials mapped (75 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01345851NA · active not recruiting Image-Guided Hypofractionated Radiation Therapy With Stereotactic Body Radiation Therapy Boost and Combination Chemotherapy in Treating Patients With Stage II-III Non-Small Cell Lung Cancer That Cannot Be Removed By Surgery · condition mapped ALIAS · 231 trials mapped (75 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05566223Phase 1/Phase 2 · withdrawn CISH Inactivated TILs in the Treatment of NSCLC · condition mapped ALIAS · 231 trials mapped (75 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07423169NA · recruiting Partial Tumor Irradiation and Immunotherapy for Unresectable Lung Cancer · condition mapped ONTOLOGY_EXACT · 231 trials mapped (75 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07235280early Phase 1 · recruiting Testing the Safety of Dapagliflozin Prior to Surgery for the Treatment of Patients With Stage IA Lung Adenocarcinoma · condition mapped ONTOLOGY_EXACT · 231 trials mapped (75 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07416058Phase 2 · not yet recruiting PHOENIX: QL1706 Plus Chemotherapy and Bevacizumab in AGA-Resistant, PD-L1 ≥50% Non-Squamous NSCLC · condition mapped ONTOLOGY_EXACT · 231 trials mapped (75 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07392073not yet recruiting Peripheral Blood ETASTs for Predicting Efficacy of Chemoimmunotherapy in NSCLC · condition mapped ONTOLOGY_EXACT · 231 trials mapped (75 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04339218Phase 3 · recruiting Cryoablation in Combination (or Not) With Pembrolizumab and Pemetrexed-carboplatin in 1st-line Treatment for Patients With Metastatic Lung Adenocarcinoma · condition mapped ONTOLOGY_EXACT · 231 trials mapped (75 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07373171NA · not yet recruiting Evaluation of Different Sizes of Left-Sided Double-Lumen Tubes for Thoracic Surgery in a Tertiary Level Teaching Hospital · condition mapped ONTOLOGY_EXACT · 231 trials mapped (75 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07287904not yet recruiting Prediction of Targeted Therapy Efficacy in EGFR-mutant Lung Cancer Patients Using AI-based Multimodal Data · condition mapped ALIAS · 231 trials mapped (75 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07273279not yet recruiting ADH1B and ALDH Gene Variants and Lung Cancer Risk · condition mapped ONTOLOGY_EXACT · 231 trials mapped (75 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04625647Phase 2 · active not recruiting Testing the Use of Targeted Treatment (AMG 510) for KRAS G12C Mutated Advanced Non-squamous Non-small Cell Lung Cancer (A Lung-MAP Treatment Trial) · condition mapped ONTOLOGY_EXACT · 231 trials mapped (75 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05194735Phase 1/Phase 2 · terminated Phase I/II Study of Autologous T Cells to Express T-Cell Receptors (TCRs) in Subjects With Solid Tumors · condition mapped ALIAS · 231 trials mapped (75 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05558904Phase 1/Phase 2 · recruiting An Investigational Scan (Me-4FDG PET/CT) for the Detection of Sodium-Glucose Transport for Early Diagnosis of Lung Cancer · condition mapped ONTOLOGY_EXACT · 231 trials mapped (75 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03184571Phase 2 · completed Bemcentinib (BGB324) in Combination With Pembrolizumab in Patients With Advanced Non-small Cell Lung Cancer (NSCLC) · condition mapped ALIAS · 231 trials mapped (75 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07169903Phase 3 · not yet recruiting Segmentectomy vs Lobectomy for 2 - 3cm IASLC Grade 1-2 Lung Adenocarcinoma: A Multi-center RCT · condition mapped ONTOLOGY_EXACT · 231 trials mapped (75 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01737502Phase 1/Phase 2 · completed Sirolimus and Auranofin in Treating Patients With Advanced or Recurrent Non-Small Cell Lung Cancer or Small Cell Lung Cancer · condition mapped ONTOLOGY_EXACT · 231 trials mapped (75 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05292859completed Long-Term Follow-up Study of Subjects Treated With Autologous T Cells Using the Sleeping Beauty System to Express TCRs · condition mapped ALIAS · 231 trials mapped (75 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06299163Phase 1 · terminated NM32-2668 in Adult Patients With Selected Advanced Solid Tumors · condition mapped ALIAS · 231 trials mapped (75 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04533451Phase 2 · active not recruiting Testing the Effects of MK-3475 (Pembrolizumab) With or Without the Usual Chemotherapy Treatment for Patients 70 Years of Age and Older With Advanced Non-small Cell Lung Cancer · condition mapped CURATED_BROADER · 231 trials mapped (75 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06477211completed DNA Methylation Biomarkers to Predict Survival After Surgery for Lung Adenocarcinoma · condition mapped ONTOLOGY_EXACT · 231 trials mapped (75 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07002788NA · active not recruiting Comparison Paravertebral and Serratus Anterior Plane Block in Video-assisted Thoracoscopic Surgery. · condition mapped ONTOLOGY_EXACT · 231 trials mapped (75 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03845296Phase 2 · completed Rucaparib in Treating Patients With Genomic LOH High and/or Deleterious BRCA1/2 Mutation Stage IV or Recurrent Non-small Cell Lung Cancer (A Lung-MAP Treatment Trial) · condition mapped CURATED_BROADER · 231 trials mapped (75 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06953492completed Sleep State in Lung Cancer: A Retrospective Analysis · condition mapped ONTOLOGY_EXACT · 231 trials mapped (75 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03054298Phase 1 · completed CAR T Cells in Mesothelin Expressing Cancers · condition mapped ONTOLOGY_EXACT · 231 trials mapped (75 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04802876Phase 2 · active not recruiting Efficacy of Tislelizumab and Spartalizumab Across Multiple Cancer-types in Patients with PD1-high MRNA Expressing Tumors · condition mapped ONTOLOGY_EXACT · 231 trials mapped (75 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03676192Phase 3 · completed To Compare Efficacy and Safety of CT-P16 and European Union-Approved Avastin as First-Line Treatment for Metastatic or Recurrent Non-Squamous Non-Small Cell Lung Cancer · condition mapped ALIAS · 231 trials mapped (75 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06858410Phase 3 · not yet recruiting Lorlatinib Compared with Concurrent/ Sequential Chemoradiotherapy in Stage III ALK Positive Lung Adenocarcinoma · condition mapped ALIAS · 231 trials mapped (75 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06818955Phase 2 · not yet recruiting Orlistat Overcoming Third-generation EGFR-TKI Resistance · condition mapped ONTOLOGY_EXACT · 231 trials mapped (75 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03371381Phase 1/Phase 2 · terminated An Efficacy and Safety Study of JNJ-64041757, a Live Attenuated Listeria Monocytogenes Immunotherapy, in Combination With Nivolumab Versus Nivolumab Monotherapy in Participants With Advanced Adenocarcinoma of the Lung · condition mapped ALIAS · 231 trials mapped (75 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04588064NA · completed 18F-FDG and 68Ga-FAPI PET/CT in Lung Adenocarcinoma · condition mapped ONTOLOGY_EXACT · 231 trials mapped (75 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01014286completed Lung Cancer Mutation Consortium Protocol · condition mapped CURATED_BROADER · 231 trials mapped (75 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06745830recruiting Lymph Node Pathologic Grading Strategy · condition mapped ONTOLOGY_EXACT · 231 trials mapped (75 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06730477enrolling by invitation Plasma Exosomes Reveal the Efficacy of Targeted Therapy in Patients With EGFR Mutation in Lung Adenocarcinoma · condition mapped ONTOLOGY_EXACT · 231 trials mapped (75 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05925764recruiting WSI Based DL for Diagnosing the IASLC Grading System of Lung Adenocarcinoma · condition mapped ONTOLOGY_EXACT · 231 trials mapped (75 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05012397Phase 2 · terminated Milademetan in Advanced/Metastatic Solid Tumors · condition mapped ONTOLOGY_EXACT · 231 trials mapped (75 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06645743not yet recruiting Retrospective Analysis of Clinical and CT Features to Predict Spread Through Air Space in Stage IA Lung Adenocarcinoma · condition mapped CURATED_BROADER · 231 trials mapped (75 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06634966Phase 3 · recruiting Segmentectomy for Solid-dominant Lung Cancer · condition mapped ONTOLOGY_EXACT · 231 trials mapped (75 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06619886early Phase 1 · not yet recruiting TP53 R248Q TCR-T Cell Therapy for Advanced Solid Tumor · condition mapped ONTOLOGY_EXACT · 231 trials mapped (75 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02264210Phase 2 · completed Icotinib for Completed Resected IB NSCLC With EGFR Mutation · condition mapped ALIAS · 231 trials mapped (75 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06215885unknown Multi-omics Analysis to Characterize the Invasive Evolution of Pulmonary Subsolid Nodules · condition mapped ALIAS · 231 trials mapped (75 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05830812recruiting Improving the Intraoperative Diagnosis Accuracy of Invasiveness for Small-sized Lung Adenocarcinoma · condition mapped CURATED_BROADER · 231 trials mapped (75 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06602661Phase 1 · not yet recruiting Reinforced and Non-Reinforced Staple Lines in Fissureless Lobectomy · condition mapped ONTOLOGY_EXACT · 231 trials mapped (75 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04944173Phase 2 · withdrawn SCION: SABR and Checkpoint Inhibition of NSCLC · condition mapped CURATED_BROADER · 231 trials mapped (75 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05794698completed Intraoperative Frozen Section Pathology to Diagnose the IASLC Grades for Lung Adenocarcinoma (ECTOP-1014) · condition mapped ONTOLOGY_EXACT · 231 trials mapped (75 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04770688Phase 1/Phase 2 · completed Advanced Lung Tumor Treated by Osimertinib Plus Anlotinib · condition mapped ALIAS · 231 trials mapped (75 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04740047completed Cios Mobile 3D Spin for Robotic Bronchoscopy · condition mapped ONTOLOGY_EXACT · 231 trials mapped (75 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02759835Phase 2 · completed Local Ablative Therapy for Treatment of Oligoprogressive, EGFR-Mutated, Non-Small Cell Lung Cancer After Treatment With Osimertinib · condition mapped ONTOLOGY_EXACT · 231 trials mapped (75 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06441357unknown Differentiating the Invasiveness of Lung Adenocarcinoma by Dual Energy CT Parameter · condition mapped ALIAS · 231 trials mapped (75 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05717803Phase 3 · recruiting Segmentectomy for Ground Glass-dominant Invasive Lung Cancer (ECTOP-1012) · condition mapped ONTOLOGY_EXACT · 231 trials mapped (75 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05266846Phase 2 · recruiting Pembrolizumab Plus Bevacizumab and Chemotherapy for ALK-rearranged NSCLC With Persistent 5'ALK · condition mapped ONTOLOGY_EXACT · 231 trials mapped (75 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05982574active not recruiting Tumor Microenvironment · condition mapped ONTOLOGY_EXACT · 231 trials mapped (75 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04027946Phase 2 · terminated LMB-100 Followed by Pembrolizumab in the Treatment of Adults With Mesothelin-Expressing Non-Squamous Non-Small Cell Lung Cancer (NSCLC) · condition mapped ALIAS · 231 trials mapped (75 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03076164Phase 1/Phase 2 · completed A Phase 1/2 Trial of Trametinib and Erlotinib in Patients With EGFR-Mutant Lung Adenocarcinomas and Acquired Resistance to Erlotinib · condition mapped ONTOLOGY_EXACT · 231 trials mapped (75 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04682431Phase 1 · terminated A Phase 1a/1b FIH Study of PY159 and in Combination With Pembrolizumab in Subjects With Advanced Solid Tumors · condition mapped ONTOLOGY_EXACT · 231 trials mapped (75 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04691375Phase 1 · terminated A Study of PY314 in Subjects With Advanced Solid Tumors · condition mapped ONTOLOGY_EXACT · 231 trials mapped (75 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04310943Phase 2 · completed Efficacy and Safety of Tislelizumab Combined With Bevacizumab and Albumin Paclitaxel in Lung Adenocarcinoma · condition mapped CURATED_BROADER · 231 trials mapped (75 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06255197recruiting Characteristics, Treatment Patterns and Outcomes for Patients With Surgically Resected Lung Cancers · condition mapped ONTOLOGY_EXACT · 231 trials mapped (75 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04046614Phase 1/Phase 2 · completed Feasibility and Safety of Nintedanib in Combination With Nivolumab in Pretreated Patients With Advanced or Metastatic NSCLC of Adenocarcinoma Histology · condition mapped ALIAS · 231 trials mapped (75 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05526573unknown Diagnostic Yeld of Ultrathin Bronchoscopy in Peripheral Pulmonary Lesions · condition mapped ONTOLOGY_EXACT · 231 trials mapped (75 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04870034early Phase 1 · withdrawn Binimetinib and Palbociclib Before Surgery for the Treatment of Operable KRAS-Positive Lung, Colorectal, or Pancreatic Cancer · condition mapped ONTOLOGY_EXACT · 231 trials mapped (75 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06031181Phase 3 · recruiting Sublobar Resection for Adenocarcinoma in Situ/Minimally Invasive Adenocarcinoma Diagnosed by Intraoperative Frozen Section (ECTOP-1019) · condition mapped ONTOLOGY_EXACT · 231 trials mapped (75 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06104709unknown Local and Peripheral Immune Responsive Landscape Induced by Local Cryoablation in Patients With Lung Adenocarcinoma · condition mapped ONTOLOGY_EXACT · 231 trials mapped (75 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05550961recruiting APOLLO 11, Consortium of Italian Centers Involved in Treatment of Patients With Lung Cancer Treated With Innovative Therapies: Real World Data and Translational Reaserch · condition mapped ALIAS · 231 trials mapped (75 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05498597Phase 1 · unknown AMT-151 in Patients With Selected Advanced Solid Tumours · condition mapped ONTOLOGY_EXACT · 231 trials mapped (75 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06056115NA · recruiting Efficacy and Safety of Tislelizumab for Lung Adenocarcinoma With Asymptomatic Brain Metastatic · condition mapped ONTOLOGY_EXACT · 231 trials mapped (75 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06031246Phase 3 · recruiting Selective Lymph Node Dissection for cT1N0M0 Invasive NSCLC With CTR>0.5 Located in the Apical Segment (ECTOP-1018) · condition mapped ONTOLOGY_EXACT · 231 trials mapped (75 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05838053recruiting Comparison of Segmentectomy Versus Lobectomy for Lung Adenocarcinoma ≤ 2cm · condition mapped ONTOLOGY_EXACT · 231 trials mapped (75 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05794711unknown Intraoperative Frozen Section Pathology to Guide Surgical Treatment for Lung Adenocarcinoma (ECTOP-1015) · condition mapped ONTOLOGY_EXACT · 231 trials mapped (75 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05794724unknown Intraoperative Frozen Section Pathology to Guide Surgical Treatment for Lung Adenocarcinoma (ECTOP-1016) · condition mapped ONTOLOGY_EXACT · 231 trials mapped (75 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04165759completed HRCT in Prediction of Tumor Invasion in GGO Lung Adenocarcinoma (ECTOP-1008) · condition mapped ALIAS · 231 trials mapped (75 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05252676completed Evaluation of Correlations Between Radiologic Features and Pathologic Subtypes of GGO LUAD Via WMS (ECTOP-1011) · condition mapped ALIAS · 231 trials mapped (75 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02980991Phase 2 · completed Pemetrexed and Platinum Use in the Neoadjuvant Setting for Resectable Stage II and IIIA Lung Adenocarcinoma (ECTOP-1002) · condition mapped ONTOLOGY_EXACT · 231 trials mapped (75 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05527808NA · unknown A Single-arm Exploratory Study of Neoadjuvant Therapy · condition mapped ONTOLOGY_EXACT · 231 trials mapped (75 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00946712Phase 3 · terminated S0819: Carboplatin and Paclitaxel With or Without Bevacizumab and/or Cetuximab in Treating Patients With Stage IV or Recurrent Non-Small Cell Lung Cancer · condition mapped CURATED_BROADER · 231 trials mapped (75 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05733000Phase 2 · recruiting CPI-613 (Devimistat) in Combination With Hydroxychloroquine and 5-fluorouracil or Gemcitabine in Treating Patients With Advanced Chemorefractory Solid Tumors · condition mapped CURATED_BROADER · 231 trials mapped (75 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03904563Phase 2 · completed Bevacizumab After Chemoradiotherapy For Locally Advanced Lung Adenocarcinoma · condition mapped ONTOLOGY_EXACT · 231 trials mapped (75 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05736991unknown Deep Learning Signature for Predicting the Novel Grading System of Clinical Stage I Lung Adenocarcinoma · condition mapped ONTOLOGY_EXACT · 231 trials mapped (75 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02120807Phase 1 · completed Certolizumab in Combination With Chemotherapy for Patients With Stage IV Lung Adenocarcinomas · condition mapped CURATED_BROADER · 231 trials mapped (75 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05675033Phase 2 · unknown Serplulimab Combined With Anti-VEGF Antibody in Advanced Lung Adenocarcinoma · condition mapped ONTOLOGY_EXACT · 231 trials mapped (75 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05537922recruiting I3LUNG: Integrative Science, Intelligent Data Platform for Individualized LUNG Cancer Care With Immunotherapy · condition mapped ONTOLOGY_EXACT · 231 trials mapped (75 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04201756Phase 2 · completed Neoadjuvant Afatinib Therapy for Potentially Resectable Stage III EGFR Mutation-Positive Lung Adenocarcinoma · condition mapped CURATED_BROADER · 231 trials mapped (75 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04459078Phase 2 · unknown Clinical Study of Camrelizumab Combined With APatinib and Albumin Paclitacxel in Patients With Advanced Lung Adenocarcinoma · condition mapped ALIAS · 231 trials mapped (75 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04861948Phase 1 · terminated IBI188 Combination Therapy in Solid Tumors · condition mapped ONTOLOGY_EXACT · 231 trials mapped (75 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05565677unknown Prognostic Value of Lung Cancer MicroAnatomy in 3D · condition mapped ALIAS · 231 trials mapped (75 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04122833unknown Impact of Concomitant Genetic Alterations in EGFR Mutated Adenocarcinoma by NGS Analysis: A Multicenter Study · condition mapped ALIAS · 231 trials mapped (75 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05503667Phase 2 · recruiting Neoadjuvant Furmonertinib Plus Bevacizumab or Furmonertinib Monotherapy for Resectable and Potentially Resectable Stage III-IVA EGFR Mutation-Positive Lung Adenocarcinoma · condition mapped CURATED_BROADER · 231 trials mapped (75 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03891173Phase 2 · terminated A Study of L-DOS47 in Combination With Vinorelbine/Cisplatin in Lung Adenocarcinoma · condition mapped ONTOLOGY_EXACT · 231 trials mapped (75 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03041181Phase 2 · terminated Single Agent Chemotherapy +/- Nivolumab in Patients With Advanced Squamous or Non-squamous NSCLC With Primary Resistance to Prior PD-1 or PDL-1 Inhibitor · condition mapped ALIAS · 231 trials mapped (75 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02535325Phase 1 · completed Methoxyamine Hydrochloride, Pemetrexed Disodium, Cisplatin, and Radiation Therapy in Treating Patients With Stage IIIA-IV Non-small Cell Lung Cancer · condition mapped CURATED_BROADER · 231 trials mapped (75 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05400304unknown Radiomics Combined With Frozen Section Prediction Model for Spread Through Air Space in Lung Adenocarcinoma · condition mapped ONTOLOGY_EXACT · 231 trials mapped (75 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05395611unknown Exhaled Breath Particles in Lung Cancer · condition mapped ONTOLOGY_EXACT · 231 trials mapped (75 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05279521NA · unknown The Effect of Interventional Pulmonary Rehabilitation Exercise With Advanced Lung Cancer. · condition mapped ONTOLOGY_EXACT · 231 trials mapped (75 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05245630completed Comparison of Robotic Arm-assisted PET/CT-guided Lung Biopsy With PET Fused CT- Fluoroscopy-guided Lung Biopsy · condition mapped ALIAS · 231 trials mapped (75 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01935336Phase 2 · completed Study of Ponatinib in Patients With Lung Cancer Preselected Using Different Candidate Predictive Biomarkers · condition mapped ALIAS · 231 trials mapped (75 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05136014unknown Evaluation of the Response to Tyrosine Kinase Inhibitors in Localized Non-small Cell Lung Cancer (NSCLC) Patients With EGFR Mutation in a Patient-derived Organoid Model · condition mapped ONTOLOGY_EXACT · 231 trials mapped (75 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05079022Phase 1/Phase 2 · unknown ctDNA-MRD Based Adjuvant Targeted Therapy for EGFR Positive Stage I Lung Adenocarcinomas · condition mapped ALIAS · 231 trials mapped (75 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03922828completed Lung Nodule Prospective Database · condition mapped ONTOLOGY_EXACT · 231 trials mapped (75 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02303977Phase 2 · completed Phase II Study of Abraxane and Gemicitabine in Patients With Advanced Adenocarcinoma Non-Small Cell Lung Cancer Progressing After First-Line Platinum-Based Chemotherapy · condition mapped ALIAS · 231 trials mapped (75 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04893200completed Radiomics-based Prediction Model of Tumor Spread Through Air Space in Lung Adenocarcinoma · condition mapped ONTOLOGY_EXACT · 231 trials mapped (75 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05010330unknown Identify Prognostic Biomarkers of Lung Cancer · condition mapped ONTOLOGY_EXACT · 231 trials mapped (75 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04965831Phase 2 · unknown Furmonertinib as Perioperation Therapy in Stage IIIA-IIIB (N1-N2) Resectable EGFR Mutated Lung Adenocarcinoma (FRONT) · condition mapped ONTOLOGY_EXACT · 231 trials mapped (75 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02621333Phase 2 · terminated Chemotherapy Combined Autologous Cytokine-induced Killer Cells in Naive Stage IV EGFR-wild Type Lung Adenocarcinoma · condition mapped ONTOLOGY_EXACT · 231 trials mapped (75 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03298763Phase 1/Phase 2 · unknown Targeted Stem Cells Expressing TRAIL as a Therapy for Lung Cancer · condition mapped ALIAS · 231 trials mapped (75 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04761640unknown The Impact of Polynuclear Neutrophils' Intra-tumoral Rate and the Mutational Status in Pulmonary Adenocarcinomas on Survival · condition mapped ALIAS · 231 trials mapped (75 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02127359completed Whole-Exome Sequencing (WES) of Cancer Patients · condition mapped ONTOLOGY_EXACT · 231 trials mapped (75 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04202614completed Prognostic Role of Positron Emission Tomography and Computed Tomography Parameters in Stage I Lung Adenocarcinoma · condition mapped ALIAS · 231 trials mapped (75 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04692935unknown Comparative Genomic Profiling of Lung Adenocarcinoma in Asians and Caucasians: A Propensity Matched Analysis · condition mapped ALIAS · 231 trials mapped (75 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02276027Phase 2 · completed A Phase II, Open Label, Multiple Arm Study of AUY922, BYL719, INC280, LDK378 and MEK162 in Chinese Patients With Advanced Non-small Cell Lung Cancer · condition mapped ALIAS · 231 trials mapped (75 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03254004Phase 2 · unknown Postoperative Pembrolizumab for the Patients Who Have Solid Predominant or Micropapillary Lung Adenocarcinoma With Pathologic Stage I and Primary Tumor Than 4 cm · condition mapped CURATED_BROADER · 231 trials mapped (75 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03896958unknown The PIONEER Initiative: Precision Insights On N-of-1 Ex Vivo Effectiveness Research Based on Individual Tumor Ownership (Precision Oncology) · condition mapped ALIAS · 231 trials mapped (75 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03361319Phase 1/Phase 2 · withdrawn Combination Nab-paclitaxel (N-P) and Nintedanib or N-P and Placebo in Relapsed NSCLC Adenocarcinoma · condition mapped ALIAS · 231 trials mapped (75 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01958372Phase 1 · completed Radiation Therapy, Chemotherapy, and Soy Isoflavones in Treating Patients With Stage IIIA-IIIB Non-Small Cell Lung Cancer · condition mapped ALIAS · 231 trials mapped (75 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02616211completed An Integrated Approach to Treating Recurrent Thoracic Carcinomas Resistant to Tyrosine Kinase Inhibitors · condition mapped ALIAS · 231 trials mapped (75 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04554875unknown Derivation and Validation of a Scoring System to Distinguish Cryptococcosis and Adenocarcinoma in Pulmonary Nodules · condition mapped ONTOLOGY_EXACT · 231 trials mapped (75 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00950365Phase 2 · completed Pemetrexed Disodium With or Without Erlotinib Hydrochloride in Treating Patients With Stage IIIB-IV or Recurrent Non-Small Cell Lung Cancer · condition mapped ONTOLOGY_EXACT · 231 trials mapped (75 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01218516Phase 2 · completed A Safety and Efficacy Study of Farletuzumab in Participants With Adenocarcinoma of the Lung · condition mapped ALIAS · 231 trials mapped (75 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04493827completed Distribution and Prognostic Impact of Oncogenic Drivers in Metastatic Lung Adenocarcinoma : a Retrospective Monocentric Study in Nancy University Hospital Center · condition mapped CURATED_BROADER · 231 trials mapped (75 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04482829NA · unknown TCM in the Treatment of Lung Adenocarcinoma · condition mapped ONTOLOGY_EXACT · 231 trials mapped (75 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02737774Phase 2 · unknown Alternating Icotinib and Chemotherapy for Advanced Non-small Cell Lung Cancer With EGFR Mutation · condition mapped ONTOLOGY_EXACT · 231 trials mapped (75 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04086680completed The Detection of EGFR Mutations in Liquid Based Cytology Samples · condition mapped ALIAS · 231 trials mapped (75 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00073398Phase 1/Phase 2 · completed Vaccine Treatment for Advanced Non-Small Cell Lung Cancer · condition mapped ALIAS · 231 trials mapped (75 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03704870Phase 2 · completed Outcomes Following Omission of Daily Routine Chest Radiographs Following Pulmonary Resection · condition mapped ONTOLOGY_EXACT · 231 trials mapped (75 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02134912Phase 2 · terminated S1300: Pemetrexed Disodium With or Without Crizotinib in Treating Patients With Stage IV Non-Small Cell Lung Cancer That Has Progressed After Crizotinib · condition mapped ALIAS · 231 trials mapped (75 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03059641completed Therapeutic ResistAnce and Clonal Evolution Assessed With Liquid Biopsy of NSCLC Patients in China · condition mapped ALIAS · 231 trials mapped (75 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01707823early Phase 1 · terminated Low-Dose Acetylsalicylic Acid in Treating Patients With Stage I-III Non-Small Cell Lung Cancer · condition mapped ALIAS · 231 trials mapped (75 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03544814Phase 2 · completed EGFR-TKI Combined With Concurrent or Sequential Chemotherapy for Patients of Gradual Progression · condition mapped ONTOLOGY_EXACT · 231 trials mapped (75 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01259089Phase 1/Phase 2 · completed Hsp90 Inhibitor AUY922 and Erlotinib Hydrochloride in Treating Patients With Stage IIIB-IV Non-Small Cell Lung Cancer · condition mapped ALIAS · 231 trials mapped (75 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02466568Phase 1/Phase 2 · withdrawn Study of Nivolumab in Combination With GM.CD40L Vaccine in Adenocarcinoma of the Lung · condition mapped ALIAS · 231 trials mapped (75 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00126581Phase 2 · completed Erlotinib Hydrochloride With or Without Carboplatin and Paclitaxel in Treating Patients With Stage III-IV Non-small Cell Lung Cancer · condition mapped ONTOLOGY_EXACT · 231 trials mapped (75 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01362790Phase 1/Phase 2 · completed SS1P and Pentostatin Plus Cyclophosphamide for Mesothelioma · condition mapped ALIAS · 231 trials mapped (75 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03905317Phase 2 · unknown Bevacizumab and Radiotherapy for Oligometastasis of Lung Adenocarcinoma With Negative Driver Gene · condition mapped ONTOLOGY_EXACT · 231 trials mapped (75 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03838588unknown The Tracking Molecular Evolution for NSCLC (T-MENC) Study · condition mapped ALIAS · 231 trials mapped (75 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02891733withdrawn Retrospective Analysis of the Expression of the Neurotensin Receptor by Metastatic Lung Adenocarcinomas · condition mapped ALIAS · 231 trials mapped (75 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01578551Phase 2 · terminated Study of Metformin Plus Paclitaxel/Carboplatin/Bevacizumab in Patients With Adenocarcinoma. · condition mapped ONTOLOGY_EXACT · 231 trials mapped (75 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01557959Phase 2 · completed Docetaxel, Cisplatin, Pegfilgrastim, and Erlotinib Hydrochloride in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer · condition mapped ALIAS · 231 trials mapped (75 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00955305Phase 2 · terminated Paclitaxel, Carboplatin, and Bevacizumab With or Without Cixutumumab in Treating Patients With Stage IV or Recurrent Non-small Cell Lung Cancer · condition mapped ONTOLOGY_EXACT · 231 trials mapped (75 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02979821Phase 2 · completed Poziotinib in Stage IV Lung Adenocarcinoma With HER2 Mutation (KASTT001) · condition mapped PROBABILISTIC · 231 trials mapped (75 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03486496Phase 2 · unknown Gefitinib and Berberine in the First-line Treatment of Lung Adenocarcinoma With EGFR Mutation · condition mapped ONTOLOGY_EXACT · 231 trials mapped (75 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02093000completed A Study Examining Maintenance Bevacizumab (Avastin®) Monotherapy in Participants With Advanced Lung Adenocarcinoma · condition mapped ONTOLOGY_EXACT · 231 trials mapped (75 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03351842Phase 2 · recruiting Surgery With or Without Chemotherapy for Stage I NSCLC With Micropapillary Component ≥ 20% · condition mapped CURATED_BROADER · 231 trials mapped (75 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03376737Phase 2 · unknown Study of Apatinib as the Maintenance Therapy in Advanced Lung Adenocarcinoma · condition mapped ONTOLOGY_EXACT · 231 trials mapped (75 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02121925terminated Registry Measuring the Impact of Adding RNA Expression Testing on Referral Decisions in Early Stage Lung Cancer Patients and Assessing the Disease-free Survival With Long-term Follow-up · condition mapped ONTOLOGY_EXACT · 231 trials mapped (75 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02715102terminated Circulating Tumor DNA in Patients at High Risk for Lung Cancer · condition mapped ALIAS · 231 trials mapped (75 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02679443NA · completed Vitamin Supplementation in NSCLC Patients on Pemetrexed Based Chemotherapy · condition mapped ONTOLOGY_EXACT · 231 trials mapped (75 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01726296NA · completed Adherence to Survivorship Care Guidelines in Health Care Providers for Non-Small Cell Lung Cancer and Colorectal Cancer Survivor Care · condition mapped ALIAS · 231 trials mapped (75 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03090815unknown Circulating Tumor DNA (ctDNA) as a Prognostic Tool in Patients With Advanced Lung Adenocarcinoma · condition mapped ALIAS · 231 trials mapped (75 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02282267NA · unknown Blood Detection of EGFR Mutation For Iressa Treatment · condition mapped ONTOLOGY_EXACT · 231 trials mapped (75 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01294306Phase 2 · completed MK2206 and Erlotinib Hydrochloride in Treating Patients With Advanced Non-Small Cell Lung Cancer Who Have Progressed After Previous Response to Erlotinib Hydrochloride Therapy · condition mapped ONTOLOGY_EXACT · 231 trials mapped (75 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02787447Phase 2 · unknown Radiotherapy Combined With Thymosin for Metastatic NSCLC Patients Who Showed Stable Disease After First Line TKI Therapy · condition mapped ONTOLOGY_EXACT · 231 trials mapped (75 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02951897NA · unknown Application of Detecting Circulating Tumor Cells in the Accurate Treatment of Early Stage Lung Adenocarcinoma · condition mapped CURATED_BROADER · 231 trials mapped (75 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02951637Phase 2 · unknown Chemotherapy Plus Gefitinib for Advanced Lung Adenocarcinoma and Sensitive EGFR Mutations: a Randomized Controlled Trial · condition mapped ONTOLOGY_EXACT · 231 trials mapped (75 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02946216unknown ALK/ROS1/MET Mutations on Plasma ctDNA in Patients With NSCLC · condition mapped ALIAS · 231 trials mapped (75 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02898857unknown Chemoresistance and Involvement of the NOTCH Pathway in Patients With Lung Adenocarcinoma · condition mapped ONTOLOGY_EXACT · 231 trials mapped (75 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02843711unknown Molecular Analysis of 150 Lung Adenocarcinoma · condition mapped ONTOLOGY_EXACT · 231 trials mapped (75 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02804646Phase 4 · unknown Endostar Durative Transfusion Combined With Chemotherapy in the Treatment of Advanced Lung Adenocarcinoma · condition mapped ALIAS · 231 trials mapped (75 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02788058Phase 2 · unknown A Study of Hypofractionated Radiotherapy for Limited Metastatic NSCLC Harboring Sensitizing EGFR Mutations After First Line TKI Therapy · condition mapped ONTOLOGY_EXACT · 231 trials mapped (75 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02738684unknown A Study to Predict Gefitinib' s Efficacy for Lung Cancer by Plasma Free Nucleic Acids EGFR Gene Mutation Test · condition mapped ONTOLOGY_EXACT · 231 trials mapped (75 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01819428Phase 2 · terminated NOV120101 (Poziotinib) for 1st Line Monotherapy in Patients With Lung Adenocarcinoma · condition mapped CURATED_BROADER · 231 trials mapped (75 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02691871Phase 1 · unknown Apatinib Plus Docetaxel as 2nd Line Treatment in Patients With Advanced Lung Adenocarcinoma Harboring Wild-type EGFR · condition mapped ONTOLOGY_EXACT · 231 trials mapped (75 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02493582Phase 2 · active not recruiting The Study of Apatinib Plus CIK as the Third Line Therapy for Advanced Lung Adenocarcinoma Patients With Wild-Type EGFR · condition mapped ALIAS · 231 trials mapped (75 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |